Management of renal anaemia: Comparison of practice in the Czech Republic and Northern England

EDTNA-ERCA Journal

Volumn 30, Issue 2, 2004, Pages 75-83

  Lindley, Elizabeth ^a,h   Pancírová, Jitka ^b,i   Kraciková, Jindra ^c   Lopot, František ^d   Green, Diane ^e   Harrington, Maurice ^e   De Vos, Jean Yves ^f   Elseviers, Monique ^g  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b Haemodialysis Centre Parallel 50   (Czech Republic)

^c NA HOMOLCE HOSPITAL   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e HOPE HOSPITAL   (United Kingdom)

^f Dialysis Unit   (Belgium)

^g UNIVERSITY OF ANTWERP   (Belgium)

^h ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

ⁱ Nemocnice Na Bulovce   (Czech Republic)

Author keywords

Anaemia; Erythropoiesis; Guidelines; Iron

Indexed keywords

ERYTHROPOIETIN; IRON;

ANEMIA; ARTICLE; CLINICAL PRACTICE; COMPARATIVE STUDY; CZECH REPUBLIC; DATA BASE; DOSE RESPONSE; DRUG COST; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HUMAN; ITALY; KIDNEY DISEASE; PILOT STUDY; PRACTICE GUIDELINE; QUESTIONNAIRE; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 3342966155     PISSN: 1019083X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2004.tb00340.x     Document Type: Article

References (17)

1. National Kidney Federation. NKF-K/DOQI Clinical practice guidelines for anaemia and chronic kidney disease: Update 2000. http://www.kidney.org/ professionals/doqi/guidelines/doqi_uptoc.html#an
2. Working Party for European Best Practice Guidelines. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrology Dialysis Transplantation 1999; 14 [Suppl 5]. http://ndt.oupjournals.org/content/vol14/suppl_5/index.shtml
3. Evans RW, Rader B, Manninen DL, Cooperative Multicenter EPO Clinical Trial Group: The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 1990; 263: 825-830.
4. Lowrie EG, Ling J, Lew NL, Yiu Y. The relative contribution of measured variables to death risk among hemodialysis patients, in Friedman EA (ed): Death on Hemodialysis: Preventable or Inevitable? 13. Boston, MA, Kluwer Academic Publishers, 1994; pp 121-141.
5. Standard cost based on a 70 kg patient on 85 units/kg/week (6000 units/week) EPO and 50 mg/week IV iron, product costs from British National Formulary No 46, September 2003.
6. UK Renal Association and Royal College of Physicians. Treatment of adults and children with renal failure: recommended standards and audit measures. 3rd Edition, 2002.
7. The Fifth Annual Report of the UK Renal Registry, December 2002. http://www.renalreg.com/home.htm
8. Will EJ, Cameron JS. European guidelines for renal anaemia-predicting 85% compliance. Nephrology Dialysis Transplantation 2000; 15 (3): 439-40.
9. Besarab A, Reyes CM, Hornberger J. Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anaemia in hemodialysis patients. American Journal of Kidney Diseases 2002; 40 (3): 439-46.
10. Horl WH, Holzer H, Mayer GJ. Osterreichische Aranesp Studiengruppe. Treatment of renal anaemia with darbepoetin alfa: results of an Austrian multicenter study. Wien Klin Wochenschr 2002; 114 (23-24): 967-71.
11. De Vos JY, Upsing L. Intravenous administration of epoetin in haemodialysis patients. EDTNA ERCA Journal 2003; 29 (3): 156-9.
12. Schaefer RM, Schaefer L. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy. Journal of Perinatal Medicine 1995; 23 (1-2): 83-8.
13. Jacobs C, Hbrl WH, Macdougall IC, Valderrábano F, Parrondo I, Segner A, Abraham IL. European Best Practice Guidelines 5 Target haemoglobin. Nephrology Dialysis Transplantation 2000; 15 [Suppl 4]: 15-19.
14. Macdougall IC, Hörl WH, Jacobs C, Valderrábano F, Parrondo I, Thompson K, Cremers S. European Best Practice Guidelines 6-8 Assessing and optimizing iron stores. Nephrology Dialysis Transplantation 2000; 15 [Suppl 4]: 20-32.
15. Jacobs C, Hörl WH, Macdougall IC, Valderróbano F, Parrondo I, Abraham IL, Segner A. European Best Practice Guidelines 9-13 Anaemia management. Nephrology Dialysis Transplantation 2000; 15 [Suppl 4]: 33-42.
16. Richardson D, Bartlett C, Will EJ. Optimizing erythropoietin therapy in hemodialysis patients. American Journal of Kidney Diseases 2001; 38 (1): 109-17.
17. Macdougall IC, Chandler G, Elston O, Harchowal J. Beneficial effects of adopting an aggressive intravenous iron policy in a hemodialysis unit. American Journal of Kidney Diseases 1999; 34 (4 Suppl 2): S40-6.